Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication

Hepatocellular carcinoma (HCC) arises in the background of chronic liver diseases, including hepatitis and liver cirrhosis caused by hepatitis C virus (HCV) infection. It is well known that HCV eradication using antiviral drugs can efficiently inhibit hepatocarcinogenesis. Recent advances in and dev...

Full description

Bibliographic Details
Main Authors:	Natsumi Oe, Haruhiko Takeda, Yuji Eso, Atsushi Takai, Hiroyuki Marusawa
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Pathogens
Subjects:	hepatitis C virus liver cancer SVR
Online Access:	https://www.mdpi.com/2076-0817/11/4/430

Similar Items

HEPATITIS C VIRUS – FROM UNKNOWN VIRUS TO A CURABLE DISEASE
by: Raluca Mihaela Dirtu, et al.
Published: (2019-06-01)

EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN
by: Arif Qayyum Khan, et al.
Published: (2020-12-01)

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
by: Masahito Nakano, et al.
Published: (2019-05-01)

Genetic Landscape of Multistep Hepatocarcinogenesis
by: Haruhiko Takeda, et al.
Published: (2022-01-01)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
by: Anca Trifan, et al.
Published: (2023-02-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
by: Chen-Ta Chi, et al.
Published: (2021-06-01)

Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication
by: Chung‐Feng Huang, et al.
Published: (2020-11-01)

Real-Life Data of Chronic Hepatitis C Patients Treated with Direct-Acting Oral Antivirals: A Single-Center Study
by: Umut Devrim Binay, et al.
Published: (2023-05-01)

Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma
by: Eun-Sook Park, et al.
Published: (2022-07-01)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
by: Jeong Won Jang, et al.
Published: (2021-01-01)

TREATMENTS OF HEPATITIS C VIRUS LIVER CIRRHOSIS WITH PEGYLAT INTERFERON-RIBAVIRIN AND INTERFERON FREE – COMPARATIVE STUDY
by: S.A. Florescu, et al.
Published: (2016-12-01)

Liver regeneration accelerates hepatitis B virus‐related tumorigenesis of hepatocellular carcinoma
by: Chiao‐Fang Teng, et al.
Published: (2018-06-01)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
by: Yun Bin Lee, et al.
Published: (2019-03-01)

The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C
by: Hidenori Toyoda, et al.
Published: (2022-01-01)

Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)
by: Waleed Attia Hassan, et al.
Published: (2023-10-01)

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy
by: Toshifumi Tada, et al.
Published: (2022-07-01)

Effect of Zinc Supplementation on Viral Response in Patients with Chronic Hepatitis C and Beta Thalassemia Major, A Pilot Study
by: Mohammad Abbasinazari, et al.
Published: (2014-12-01)

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
by: Maha M Elsabaawy, et al.
Published: (2019-01-01)

Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers
by: Kenji Imai, et al.
Published: (2021-11-01)

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma
by: Liang B, et al.
Published: (2018-01-01)

Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo
by: Patrícia Lofêgo Gonçalves, et al.
Published: (2014-10-01)

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study
by: Yu‐Chi Lee, et al.
Published: (2021-10-01)

Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma
by: Zhiyong Du, et al.
Published: (2023-05-01)

An Update on Hepatocellular Carcinoma in Chronic Kidney Disease
by: Fabrizio Fabrizi, et al.
Published: (2021-07-01)

Safety and Efficacy of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C in Population Aged 60 Years and Older in Upper Egypt
by: Ali A. Ghweil, et al.
Published: (2023-01-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection
by: Tasuku Nakabori, et al.
Published: (2022-05-01)

Hepatitis E
by: Ozzie Anis
Published: (2019-07-01)

Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies
by: Aleksei Suslov, et al.
Published: (2022-11-01)

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
by: Xinhe Zhang, et al.
Published: (2021-09-01)

Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
by: Hyung Joon Yim, et al.
Published: (2024-02-01)

Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
by: Saba Khaliq, et al.
Published: (2018-11-01)

Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic Individuals
by: Angelo Armandi, et al.
Published: (2022-08-01)

THE ROLE OF HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA PATHOGENESIS – A PROBLEM OF A MODERN MAN
by: Bojan Ilić, et al.
Published: (2009-04-01)

Clinical study of lenvatinib in the treatment of hepatitis virus-related hepatocellular carcinoma and antiviral therapy
by: Xiaomi Li, et al.
Published: (2023-01-01)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
by: Chen Shen, et al.
Published: (2023-01-01)

Co occurrence of Hepatitis B Virus Infection and Autoimmune Hepatitis with Marked Hepatitis B Virus Replication Following Treatment of Autoimmune Hepatitis
by: Tyagi I, et al.
Published: (2015-10-01)

Viral elimination is essential for improving surgical outcomes of hepatitis C virus‐related hepatocellular carcinoma: Multicenter retrospective analysis
by: Masao Nakajima, et al.
Published: (2020-11-01)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
by: Yuji Eso, et al.
Published: (2021-10-01)